Effect of N-benzoyl-D-phenylalanine and metformin on insulin receptors in neonatal streptozotocin-induced diabetic rats: Studies on insulin binding to erythrocytes

Archives of Physiology and Biochemistry

Volumn 112, Issue 3, 2006, Pages 174-181

  Ashokkumar, N ^a   Pari, L ^a   Rao, Ch Appa ^b  

^a ANNAMALAI UNIVERSITY   (India)

^b SRI VENKATESWARA UNIVERSITY   (India)

Author keywords

Insulin binding sites; Insulin receptor; Metformin; N Benzoyl D phenylalanine; Streptozotocin

Indexed keywords

DEXTRO PHENYLALANINE; GLUCOSE; INSULIN; INSULIN RECEPTOR; METFORMIN; N BENZOYL DEXTRO PHENYLALANINE; N BENZOYLPHENYLALANINE; STREPTOZOCIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFECT; DRUG RECEPTOR BINDING; ERYTHROCYTE; ERYTHROCYTE MEMBRANE; GLUCOSE BLOOD LEVEL; INSULIN BINDING; INSULIN BLOOD LEVEL; MALE; NEWBORN; NONHUMAN; RAT; RECEPTOR AFFINITY; SCATCHARD PLOT;

ANIMALS; ANIMALS, NEWBORN; BINDING, COMPETITIVE; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; ERYTHROCYTE MEMBRANE; FEMALE; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; MALE; METFORMIN; PHENYLALANINE; PREGNANCY; PROTEIN BINDING; RATS; RATS, WISTAR; RECEPTOR, INSULIN; STREPTOZOCIN;

RATTUS NORVEGICUS;

EID: 33845339680     PISSN: 13813455     EISSN: 17444160     Source Type: Journal    
DOI: 10.1080/13813450600935339     Document Type: Article

References (46)

1. Ashokkumar N, Pari L. 2005. Effect of N-benzoyl-D-phenylalanine and metformin on carbohydrate metabolic enzymes in neonatal streptozotocin diabetic rats. Clin Chim Acta 351:105-13.
2. Ashokkumar N, Pari L, Manimekalai A, Selvaraju K. 2005. Effect of N-benzoyl-D-phenylalanine on streptozotocin-induced changes in the lipid and lipoprotein profile in rats. J Pharm Pharmacol 57:359-66.
3. Bailey CJ, Turner RC. 1996. Metformin. New Engl J Md 334:574-9.
4. Bonner Weir S, Trent DF, Honey RN, Weir GC. 1981. Response of neonatal rat islets to streptozotocin. Limited β-cell regeneration and hyperglycemia. Diabetes 30:64-9.
5. Bortoli S, Amessou M, Collinet M, Desbuquois B, Lopez S. 1997. Vanadate, but not insulin, inhibits insulin receptor gene expression in rat hepatoma cells. Endocrinology 138:4821-9.
6. Cheatham B, Kahn CR. 1995. Insulin action and the insulin signaling network. Endocr Rev 16:117-42.
7. Christiansen MP, Linfoot PA, Neese RA, Hellerstein M. 1997. Metformin effects upon post absorptive intra hepatic carbohydrate fluxes. Diabetes 46(Suppl 1):244A.
8. Clark S, Harrison LC. 1983. Disulfide exchange between insulin and its receptor. A possible post-binding step in insulin action. J Biol Chem 258:11434-7.
9. Cusi K, DeFronzo RA. 1998. Metformin: a review of its metabolic effects. Diabetes Rev 6:98-131.
10. Cusi K, Consoli A, DeFronzo RA. 1996. Metabolic effect of metformin on glucose and lactate metebolism in non-insulin dependent diabetes mellitus. J Clin Endocrinol Metab 81:4059-67.
11. DePirro R, Fusco A, Lauro R, Testa I, Ferreti F, DeMartinis C. 1980. Erythrocyte insulin receptors in non-insulin-dependent diabetes mellitus. Diabetes 29:96-9.
12. Dons RF, Ryan J, Gorden P, Wachslicht-Rodbard H. 1981. Erythrocyte and monocyte insulin binding in man: a comparative analysis in normal and disease states. Diabetes 30:896-902.
13. Duncan BD. 1957. Multiple range tests for correlated and heteroscedastic means. Biometrics 13:359-64.
14. Frank HJ, Pardridge WM, Jankovic-Vokes T, Vinters HV, Morris WL. 1986. Insulin binding to the blood-brain barrier in the streptozotocin diabetic rat. J Neurochem 47:405-11.
15. Gambhir KK, Archer JA, Bradley CJ. 1978. Characteristics of human erythrocyte insulin receptors. Diabetes 27:701-8.
16. Grigorescu F, White MF, Kahn CR. 1983. Insulin binding and insulin-dependent phosphorylation of the insulin receptor solubilized from human erythrocytes. J Biol Chem 258:13708-16.
17. Hamer I, Foti M, Emkey R, Cordier-Bussat M, Philippe J, De Meyts P, Maeder C, Kahn CR, Carpentier JL. 2002. An arginine to cysteine (252) mutation in insulin receptors from patients with severe insulin resistance inhibits receptor internalization but preserves signalling events. Diabetologia 45:657-67.
18. Harmon JT, Kahn CR, Kempner ES, Schlegel W. 1980. Characterization of the insulin receptor in its membrane environment by radiation inactivation. J Biol Chem 255:3412-9.
19. Insel JR, Kolterman OG, Saekow M, Olefsky JM. 1980. Short-term regulation of insulin receptor affinity in man. Diabetes 29:132-9.
20. Kasuga M, Zick Y, Blithe DL, Crettaz M, Kahn CR. 1982. Insulin stimulates tyrosine phosphorylation of the insulin receptor in a cell-free system. Nature 298:667-9.
21. Kolterman OG, Gray RS, Griffin J, Burstein J, Sinse J, Scarlett JA, Olefsky JM. 1981. Receptor and post-receptor defects contribute to the insulin resistance in non-insulin dependent diabetes mellitus. J Clin Invest 68:957-69.
22. Lee J, Pilch PF. 1994. The insulin receptor: structure, function, and signaling. Am J Physiol 266:C319-34.
23. 2+)i oscillations in mouse pancreatic islets. Biochem Pharmacol 62:923-8.
24. McElduff A, Eastman CJ. 1981. The ER insulin receptor. Aust J Exp Biol Med Sci 59:439-48.
25. McGrowder D, Ragoobirsingh D, Dasgupta T. 2003. The effect of S-nitrosoglutathione on insulin receptor behavior on erythrocytes in an animal model. Diabetologia Croatica 32:65-71.
26. O'Neil MJ. 2001. Metformin the merck index. 13th ed. Rahway: Merck & Co. Inc.; p. 5966.
27. Okada Y. 1981. Increased insulin binding to erythrocytes in chronic liver disease. Acta Med Okayama 35:155-64.
28. Okada Y, Yoshida M, Baba S, Shii K. 1998. Development of vanadate sensitive human erythrocytes insulin receptor tyrosine phosphatase assay. Diabetes Res Clin Pract 4:157-63.
29. Olefsky JM, Kolterman OG. 1981. Mechanisms of insulin resistance in obesity and non-insulin dependent (Type II) diabetes. Am J Med 70:151-68.
30. Olefsky JM, Reaven GM. 1976. Effects of sulphonylurea therapy on insulin binding to mononuclear leukocytes of diabetic patients. Am J Med 60:89-95.
31. Patane G, Piro S, Anello M, Rabuazzo AM, Vigneri R, Purrellos F. 2000. Exposure to glibenclamide increases rat beta cells sensitivity to glucose. Br J Pharmacol 129:887-92.
32. Pollet RJ, Haase BA, Standaert ML. 1981. Characterization of detergent-solubilized membrane proteins. Hydrodynamic and sedimentation equilibrium properties of the insulin receptor of the cultured human lymphoblastoid cell. J Biol Chem 256:12118-26.
33. Proks P, Reimann F, Green N, Gribble F, Ashcroft F. 2002. Sulfonylurea stimulation of insulin secretion. Diabetes 51:S368-76.
34. Ragoobirsingh D, Robinson HM, Morrison EY. 1990. Insulin receptor studies of erythorcytes and mononuclear leucocytes in phasic insulin diabetes mellitus. West Indian Med J 39:144-7.
35. Rendell MS, Glazer NB, Zhan Ye. 2003. Combination therapy with pioglitazone plus metformin or sulfonylurea in patients with type 2 diabetes influence of prior antidiabetic drug regimen. J Diabetes Complicat 17:211-7.
36. Sasaki T, Matsy S, Sonae A. 1972. Effect of acetic acid concentration on the colour reaction in the O-toluidine boric acid method for blood glucose estimation. Rinsh Kagaku 1:346-53.
37. Scatchard G. 1949. The attraction of proteins for small molecules and ions. Ann NY Acad Sci 51:660-72.
38. Slater TF. 1984. Free radical mechanisms in tissue injury. Biochem J 22:1-15.
39. Soon YY, Tan BKH. 2000. Evaluation of the hypoglycemic and antioxidant activities of Morida officinalis in streptozotocin induced diabetes rats. Singapore Med J 43:77-85.
40. Stumvoll M, Nurjhan N, Periello G, Dailey G, Gerich JE. 1995. Metabolic effects of metformin in non-insulin dependent diabetes mellitus. New Engl J Med 333:550-4.
41. Sukhinder K, Cheema M, Thomas C. 2001. Diet and diabetes induced change in insulin binding to the nuclear membrane in spontaneously diabetic rats is associated with change in the fatty acid composition of phophatidylinositol. J Nutr Biochem 12:213-8.
42. Susheela L, Ramachandran A, Mohan V, Sheeja S, Viswanathan M. 1987. Erythrocyte insulin receptor abnormalities. J Assoc Physicians India 35:337-9.
43. Tomasevic N, Nikoli M, Klappe K, Hoekstra D, Niketi V. 2003. Insulin-induced lipid binding to hemoglobin. J Serb Chem Soc 68:25-33.
44. Vogel AI. 1987. Elementary practical organic chemistry, part 1. 2nd ed. New Delhi: CBS Publishers and Distributors; p. 270.
45. Ward GM, Harrison LC. 1986. Structure of the human ER insulin receptor. Diabetes 35:101-5.
46. Yamaguchi YF, Choi S, Sakamoto Y, Itakura K. 1983. Purification of insulin receptor with full binding activity. J Biol Chem 258:5045-9.